Appeal For Medical Devices For Syrian Humanitarian Effort

In short

Crimson Life Sciences, a division of TransPerfect, has published a list of medical devices and equipment needed to support humanitarian efforts in Syria. Donated medical devices are urgently needed by doctors treating civilian casualties of the Syrian regime. Donations are being accepted as part of the Syrian American Medical Society’s (SAMS) “Save Syrian Lives” campaign.


Events of the past year in Syria have saddened and horrified caring people around the world. Among the many troubling issues to emerge from the conflict has been the regime’s denial of medical treatment for injured civilians, forcing many to flee to refugee camps to receive medical attention. Although field hospitals have been established in Turkey and Jordan, medical devices and materials are in extremely short supply.

To provide assistance, SAMS has established the “Save Syrian Lives” campaign to accept donated medical devices. The list of requested devices is available on the Crimson website here, along with an appeal letter from Dr. Bassel Atassi of SAMS. The requested equipment list is also available as a downloadable Excel file from the site.

Crimson has already played an active role in Syrian relief efforts. Explains Crimson’s President, Marc Miller, “Several months ago, Crimson provided pro bono translations for devices meant to safeguard individuals against chemical weapons. Personally, I was very affected by the numerous reports of systematic killing of civilians and children as young as 12 years old by Syrian government forces.”

In addition to SAMS, Crimson is working with one of the nation’s leading associations of medical device manufacturers, MassMEDIC, to solicit in-kind donations. MassMEDIC’s President, Thomas J. Sommer, provided support and visibility for this worthwhile cause at the association’s recent Annual Conference in Boston.

About Crimson Life Sciences

Crimson Life Sciences is a division of TransPerfect Translations International, Inc. and is the only translation practice exclusively devoted to the medical device industry. Crimson is the world’s first translation firm certified to both ISO 13485 and ISO 9001 and the only translation firm certified to ISO 14971. Crimson’s ISO 14971-certified risk management system is the basis for the world’s only translation risk management patent (U. S. Patent No. 8,140,322 B2). TransPerfect, certified to ISO 9001 and EN 15038, is the world’s largest privately held language services provider with more than 70 offices worldwide. For more information, visit .

SOURCE: Crimson Life Sciences, Business Wire